Aptose Biosciences to sell 40M shares at 0.20 in public offering
| APTODelisted Stock | USD 2.01 0.91 82.73% |
About 55% of Aptose Biosciences' investors are presently thinking to get in. The analysis of current outlook of investing in Aptose Biosciences suggests that some traders are interested regarding Aptose Biosciences' prospects. Aptose Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Aptose Biosciences. Many technical investors use Aptose Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aptose |
Aptose Biosciences announces public offering at 0.20 per share to raise 8M for working capital.
Read at seekingalpha.com
 |
Aptose Biosciences Fundamental Analysis
We analyze Aptose Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Aptose Biosciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Aptose Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptose Biosciences stock to make a market-neutral strategy. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with similar companies.
Peers
Aptose Biosciences Related Equities
| MBIO | Mustang Bio | 6.90 | ||||
| ADAP | Adaptimmune Therapeutics | 3.57 | ||||
| SPRO | Spero Therapeutics | 1.47 | ||||
| CTMX | CytomX Therapeutics | 0.97 | ||||
| TIL | Instil Bio | 1.34 | ||||
| CRVS | Corvus Pharmaceuticals | 1.36 | ||||
| FBIOP | Fortress Biotech | 2.35 | ||||
| GANX | Gain Therapeutics | 2.55 | ||||
| FBIO | Fortress Biotech | 2.86 | ||||
| LTRN | Lantern Pharma | 3.06 | ||||
| LPTX | Leap Therapeutics | 5.26 | ||||
| ASMB | Assembly Biosciences | 6.08 | ||||
| INAB | In8bio | 13.33 | ||||
| AFMD | Affimed NV | 35.71 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |